UK Markets open in 7 hrs 19 mins
NIKKEI 225
26,804.60 -244.87 (-0.91%) HANG SENG
21,996.89 -422.08 (-1.88%) CRUDE OIL
109.61 -0.17 (-0.15%) GOLD FUTURES
1,819.80 +2.30 (+0.13%) DOW
31,029.31 +82.32 (+0.27%) BTC-GBP
16,584.72 -219.71 (-1.31%)
Laboratory Corporation of America Holdings (LH)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 235.96 |
| Open | 236.22 |
| Bid | 239.49 x 1100 |
| Ask | 244.52 x 800 |
| Day's range | 235.42 - 241.10 |
| 52-week range | 212.40 - 317.17 |
| Volume | |
| Avg. volume | 891,804 |
| Market cap | 22.968B |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | 8.51 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.88 (1.18%) |
| Ex-dividend date | 18 May 2022 |
| 1y target est | N/A |
- Zacks
LabCorp (LH) Partners HealthVerity to Grow in Drug Development
According to LabCorp (LH), this partnership is expected to broaden its comprehensive, end-to-end drug development and clinical trial programs.
- Zacks
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
Investors are optimistic about LabCorp's (LH) robust Drug Development business performance and several pandemic-related developments.
- Zacks
LabCorp (LH) Gets FDA Nod for VirSeq SARS-CoV-2 NGS Test
LabCorp's (LH) VirSeq SARS-CoV-2 NGS Test can detect specific SARS-CoV-2 strains to help health care providers make appropriate patient treatment decisions.
© 2022 Yahoo. All rights reserved.
